N/A N=101 Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec
Asthma
Primary: Indirect Cost of Asthma Per Participant Per 3 Months at Baseline (BL) and 12-month Follow-up (FUP) — 253.3; 70.4; 16.9; 17.1 US Dollars
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=292 Asthma in Central Texas Project
Asthma
Primary: Absenteeism, End of Study — 3.83; 4.41; 3.68 percentage of days enrolled
N/A N=39 Inflammation and Corticosteroid Responsiveness in Severe Asthma
Asthma
Primary: Lung Function FEV1 — 84.9; 59.9 % of predicted — p=0.001
N/A N=849 The Electronic Asthma Action Plan System for Implementation in Primary Care
Asthma
Primary: Number of Participants to Whom an AAP (Asthma Action Plan) Was Delivered by the Clinician — 0; 79 Participants
N/A N=56 Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19
Asthma
Primary: Insurance Coverage — 11; 17; 1; 8 Participants
N/A N=28 Adapting Body Reprogramming for Severe Asthma: a Feasibility Study
Severe Asthma
Primary: Number of Participants Taking Part Who Completed All 4 Weeks of the Course — 13 Participants
Phase 2 N=371 Peer Led Asthma Self Management for Adolescents: PLASMA
Asthma
Primary: The Pediatric Asthma Quality of Life Questionnaire (PAQOL) — 5.58; 5.93; 6.49 score on a scale — p=.043
Phase 4 N=1,220 Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief
Asthma
Primary: Rate of Asthma Exacerbations Per Year — 0.69; 0.82 Adjusted annualized exacerbations — p=0.048
Phase 4 N=139 Antidepressant Treatment at an Inner City Asthma Clinic
Depression · Asthma
Primary: Asthma Control Questionnaire (ACQ) — 1.15; 1.63; 1.39; 1.23 units on a scale
Phase 4 N=52 Positive Expiratory Pressure for the Treatment of Acute Asthma in Children
Asthma
Primary: Change in Pulmonary Asthma Score (PAS) — 0.9; 0.4 mean PAS score
Phase 4 N=221 Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
Asthma
Primary: Percentage of Well Controlled Participants as Per Gaining Optimal Asthma Control (GOAL) Criteria After 12 Week Compared to Percentage of Participants With Asthma Control…
Phase 2 N=18 Biomarkers of Irritant-Induced and Allergic Asthma
Asthma
Primary: Change in TSLP Gene Expression — 0.000197; 0.000035 Fold Change
N/A N=12,238 Asthma in Families Facing Out-of-pocket Requirements With Deductibles
Asthma
Primary: Change in Percentage of Days Covered for Inhaled Corticosteroids — 51.5; 44.7; 37.0; 29.1 percentage of days — p=0.05
N/A N=384 Telemedicine Enhanced Asthma Management Through the Emergency Department
Asthma
Primary: Number of Symptom-Free Days in the Prior 2 Weeks — 9.5; 10.1 days
Phase 2 N=15 A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
Severe, Refractory Asthma · Airway Inflammation · Airflow Obstruction
Primary: 16 Weeks - Juniper Asthma Quality of Life Questionnaire (AQLQ) Score — 4.7; 4.6 units on a scale